Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Efficacy and Safety of Tapentadol Oral Solution in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Subjects Aged From Birth to Less Than 18 Years Old

NCT02081391 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT02081391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02081391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Efficacy and Safety of Tapentadol Oral Solution in the Treatment of Post-operative Acute Pain Requiring Opioid Treatment in Pediatric Subjects Aged From Birth to Less Than 18 Years Old
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2015
Completion date
March 14, 2019
Enrollment
216 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain